A new MRSA test

Alere introduced its new PBP2a test, a rapid, lateralflow assay that detects the PBP2a protein found in MRSA directly from Staphylococcus aureus isolates. It is a costeffective, targeted approach to identifying MRSA, the firm points out. Providing results in five minutes, the assay uses samples from cultures (wound, skin, urine, etc.) and has builtin quality controls on every test strip.

Photo: A new MRSA test

11.07.2012

Read all latest stories

Related articles

Photo

EMA recommandation for Ervebo

Ebola: first vaccine to protect against deadly virus

It is an important step towards fighting one of the deadliest viruses known to man: The human medicines committee (CHMP) of the European Medicines Agency (EMA) has recommended granting a conditional…

Photo

Combatting nosocomial infections

A&E Staphylococci POCT

Martin Möckel and Dorothee Riedlinger, from the Charité Medical University Berlin, Emergency and Acute Medicine Campus Virchow-Klinikum, and Campus Charité-Mitte report on POCT testing in the…

Photo

Pathogenic microbes

Cigarette smoke makes MRSA superbug bacterium more drug-resistant

Cigarette smoke can make MRSA bacterial strains more resistant to antibiotics, new research from the University of Bath has shown. In addition cigarette smoke exposure can make some strains of…

Related products

Atlas Genetics - Atlas Genetics io system

Infectious diseases testing

Atlas Genetics - Atlas Genetics io system

Atlas Genetics Ltd
Siemens Healthineers – Versant HCV Genotype 2.0 Assay (LiPA)

Infectious Disease/Hepatitis

Siemens Healthineers – Versant HCV Genotype 2.0 Assay (LiPA)

Siemens Healthineers